Clinical Trial Update: Adaptive Goal-Directed Adherence Tracking and Enhancement [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from Talaria, Inc. on an adaptive goal-directed adherence tracking and enhancement intervention for alcohol use disorder, which ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: Talaria, Inc | Conditions: Alcohol Abuse | Phase 2 | Status: COMPLETED